Patient-reported anxiety and depression measures for use in Indian head and neck cancer populations: a psychometric evaluation.


Journal

Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688

Informations de publication

Date de publication:
07 Jun 2021
Historique:
received: 17 10 2020
accepted: 06 05 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 8 6 2021
Statut: epublish

Résumé

Head and neck cancers (HNC) are one of the most traumatic forms of cancer because they affect essential aspects of life such as speech, swallowing, eating and disfigurement. HNCs are common in India, with over 100,000 cases being registered each year. HNC and treatment are both associated with considerable anxiety and depression. With increasing multinational research, no suitable measures in Indian languages are available to assess anxiety and depression in Indian HNC patients. This study evaluated the psychometric properties of cross-culturally adapted versions of Zung's self-rating Anxiety Scale (SAS) and the Patient health questionnaire - 9 (PHQ-9) in Tamil, Telugu and Hindi speaking Indian HNC populations. HNC patients were recruited from three tertiary cancer centres in India. Patients completed the cross-culturally adapted versions of SAS and PHQ-9. We assessed targeting, scaling assumptions, construct validity (exploratory and confirmatory factor analyses), convergent validity, and internal consistency reliability. The study sample included 205 Tamil, 216 Telugu and 200 Hindi speaking HNC patients. Exploratory and confirmatory factor analyses indicated a two-factor solution for PHQ-9 and four-factor solution for SAS in all three languages. Cronbach's alpha coefficients ranged between 0.717 and 0.890 for PHQ-9 and between 0.803 and 0.868 for SAS, indicating good reliability. Correlations between hypothesized scales were as expected providing evidence towards convergent validity. This first psychometric evaluation of the measurement properties of Tamil, Telugu and Hindi versions of the SAS and PHQ-9 in large, Indian HNC populations supported their use as severity and outcome measures across the disease and treatment continuum.

Sections du résumé

BACKGROUND BACKGROUND
Head and neck cancers (HNC) are one of the most traumatic forms of cancer because they affect essential aspects of life such as speech, swallowing, eating and disfigurement. HNCs are common in India, with over 100,000 cases being registered each year. HNC and treatment are both associated with considerable anxiety and depression. With increasing multinational research, no suitable measures in Indian languages are available to assess anxiety and depression in Indian HNC patients. This study evaluated the psychometric properties of cross-culturally adapted versions of Zung's self-rating Anxiety Scale (SAS) and the Patient health questionnaire - 9 (PHQ-9) in Tamil, Telugu and Hindi speaking Indian HNC populations.
METHODS METHODS
HNC patients were recruited from three tertiary cancer centres in India. Patients completed the cross-culturally adapted versions of SAS and PHQ-9. We assessed targeting, scaling assumptions, construct validity (exploratory and confirmatory factor analyses), convergent validity, and internal consistency reliability.
RESULTS RESULTS
The study sample included 205 Tamil, 216 Telugu and 200 Hindi speaking HNC patients. Exploratory and confirmatory factor analyses indicated a two-factor solution for PHQ-9 and four-factor solution for SAS in all three languages. Cronbach's alpha coefficients ranged between 0.717 and 0.890 for PHQ-9 and between 0.803 and 0.868 for SAS, indicating good reliability. Correlations between hypothesized scales were as expected providing evidence towards convergent validity.
CONCLUSIONS CONCLUSIONS
This first psychometric evaluation of the measurement properties of Tamil, Telugu and Hindi versions of the SAS and PHQ-9 in large, Indian HNC populations supported their use as severity and outcome measures across the disease and treatment continuum.

Identifiants

pubmed: 34097161
doi: 10.1186/s41687-021-00316-y
pii: 10.1186/s41687-021-00316-y
pmc: PMC8184912
doi:

Types de publication

Journal Article

Langues

eng

Pagination

44

Subventions

Organisme : The University of Sydney
ID : 2018

Références

J Cancer Res Ther. 2020 Apr-Jun;16(3):500-507
pubmed: 32719257
Fortschr Neurol Psychiatr. 2000 Apr;68 Suppl 1:S13-21
pubmed: 10907608
BMC Psychiatry. 2016 Feb 02;16:22
pubmed: 26831145
Support Care Cancer. 2019 Oct;27(10):3657-3666
pubmed: 31203508
Support Care Cancer. 1996 May;4(3):186-90
pubmed: 8739650
Eur J Cancer. 2000 Sep;36(14):1796-807
pubmed: 10974628
J Clin Oncol. 1999 Mar;17(3):1008-19
pubmed: 10071296
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Psychosomatics. 1971 Nov-Dec;12(6):371-9
pubmed: 5172928
J Affect Disord. 2016 Mar 15;193:267-73
pubmed: 26774513
Int J Oral Maxillofac Surg. 2009 Sep;38(9):955-9
pubmed: 19446438
BMC Psychiatry. 2017 Sep 8;17(1):329
pubmed: 28886698
BMC Psychiatry. 2016 Mar 08;16:58
pubmed: 26951403
Depress Res Treat. 2018 Jan 21;2018:9250972
pubmed: 29610683
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Cancer. 2011 Jan 1;117(1):218-27
pubmed: 20737537
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Patient Rep Outcomes. 2020 Apr 23;4(1):26
pubmed: 32328839
Psychooncology. 2019 Dec;28(12):2295-2306
pubmed: 31654540
Psychiatry Res. 2019 Jan;271:532-534
pubmed: 30553100
J Glob Oncol. 2019 Jul;5:1-15
pubmed: 31373840
Cogn Behav Ther. 2011;40(2):126-36
pubmed: 25155813
Br J Psychiatry. 1991 Mar;158:379-86
pubmed: 2036538
Qual Life Res. 2021 Apr 2;:
pubmed: 33797687
Br J Oral Maxillofac Surg. 2001 Feb;39(1):67-70
pubmed: 11178847
Neuropsychiatr Dis Treat. 2016 Apr 27;12:1029-36
pubmed: 27175080
Psychooncology. 2007 Jul;16(7):660-7
pubmed: 17086572
J Anxiety Disord. 2006;20(5):543-61
pubmed: 16198532
Psychol Rep. 1977 Feb;40(1):303-6
pubmed: 840986
Eur J Cancer Care (Engl). 2015 Sep;24(5):748-60
pubmed: 26250705
BMC Psychiatry. 2020 Feb 28;20(1):90
pubmed: 32111187
Br J Gen Pract. 2008 Jan;58(546):32-6
pubmed: 18186994
Am J Health Behav. 2007 Sep-Oct;31 Suppl 1:S122-33
pubmed: 17931131
J Cancer Educ. 2020 Jun;35(3):462-469
pubmed: 30715673
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Consult Clin Psychol. 1975 Jun;43(3):434
pubmed: 1159140
Head Neck. 2013 Oct;35(10):1490-8
pubmed: 23169304
Am J Psychiatry. 1986 Nov;143(11):1471-2
pubmed: 3777244
Indian J Med Res. 2005 Nov;122(5):395-9
pubmed: 16456252
Front Psychol. 2014 Nov 17;5:1332
pubmed: 25452741
Psychooncology. 2007 Jun;16(6):582-6
pubmed: 17109494

Auteurs

Chindhu Shunmugasundaram (C)

Faculty of Science, School of Psychology, Centre for Medical Psychology and Evidence-based Decision-making, The University of Sydney, Sydney, New South Wales, Australia. chindhu.shunmugasundaram@sydney.edu.au.
Faculty of Science, School of Psychology, Psycho-Oncology Cooperative Research Group, The University of Sydney, Sydney, New South Wales, Australia. chindhu.shunmugasundaram@sydney.edu.au.

Haryana M Dhillon (HM)

Faculty of Science, School of Psychology, Centre for Medical Psychology and Evidence-based Decision-making, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Science, School of Psychology, Psycho-Oncology Cooperative Research Group, The University of Sydney, Sydney, New South Wales, Australia.

Phyllis N Butow (PN)

Faculty of Science, School of Psychology, Centre for Medical Psychology and Evidence-based Decision-making, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Science, School of Psychology, Psycho-Oncology Cooperative Research Group, The University of Sydney, Sydney, New South Wales, Australia.

Puma Sundaresan (P)

Radiation Oncology Network, Western Sydney Local Health District, Sydney, New South Wales, Australia.
Sydney Medical School, Faculty of Health & Medicine, The University of Sydney, Sydney, New South Wales, Australia.

Mahati Chittem (M)

Department of Liberal Arts, Indian Institute of Technology Hyderabad, Sangareddy District, India.

Niveditha Akula (N)

Department of Liberal Arts, Indian Institute of Technology Hyderabad, Sangareddy District, India.

Surendran Veeraiah (S)

Department of Psycho-Oncology, Cancer Institute (WIA), Chennai, India.

Claudia Rutherford (C)

Faculty of Science, School of Psychology, Quality of Life Office, The University of Sydney, Sydney, New South Wales, Australia.
Susan Wakil School of Nursing and Midwifery, Cancer Nursing Research Unit, The University of Sydney, Sydney, Australia.

Classifications MeSH